AGP Executive Report
Last update: 12 hours agoRegulation & Access: India is tightening cough syrup sales by requiring a doctor’s prescription for all syrups, aiming to curb misuse and reduce delays in diagnosis. Drug Pricing & Supply Chains: Colorado won federal approval to import select prescription drugs from Canada, a move officials say could cut costs for patients over time. Health Insurance Turnaround: Aetna’s Steve Nelson is credited with improving CVS/Aetna performance after a tough period of rising care costs, highlighting insurer strategy shifts. Cancer Care & Safety: A woman says her GP missed warning signs after an “all-clear” for aggressive breast cancer, with later scans showing spread—an urgent reminder about symptom follow-up. Cancer Breakthroughs: Tang Prize laureates spotlight decades of work behind TIL and CAR-T therapies, emphasizing persistence and patient-driven innovation. Biopharma Manufacturing: West Pharmaceutical is showcasing its integrated prefillable syringe system for China’s biologics and vaccine developers at CPHI China 2026. Diabetes Innovation: Retatrutide showed strong phase 3 results for type 2 diabetes, with major HbA1c and weight reductions versus placebo. Medtech Cybersecurity: iRhythm disclosed a cyber incident tied to third-party apps, saying it found no impact on device systems or patient safety. Primary Care Workforce: A Canada report urges lessons from Scotland and Ontario to fix family-doctor shortages and reduce health inequities. Women’s Health: Menopausal hormone therapy may lower osteoporosis risk, adding a bone-protection angle to the treatment conversation.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.